VII Multidyscyplinarna Konferencja Nauki o Leku

 on-line journal

Time
 Duration
 Type
 Presenting person
 Title

Date Unspecified
Invited oral Maciej Wieczorek RNAi - breakthrough technology gives hope for breakthrough therapeutics

May 10th, Monday

09:15 00:30:00 Invited oral Jacek Kuźnicki High throughput calcium screens for identification of drug targets and drug discovery in neurodegenerative diseases 
09:45 00:30:00 Invited oral Karol L. Grela Olefin metathesis as an emerging tool in the synthesis of natural and bioactive compounds
10:15 00:20:00 Oral Zdzisław Chilmonczyk Alkyl-nitroquipazine derivatives as serotonin transporter and 5-HT1A receptor ligands
10:35 00:20:00 Oral Michał Fedoryński An efficient preparation of 3,5-bis(2-cyanoisopropyl) toluene-key intermediate in Anastrozole synthesis
11:30 00:30:00 Invited oral Andrzej Kutner Synthetic Technologies of Pharmaceutical Substances
12:00 00:20:00 Oral Katarzyna Kulig Design and synthesis of hybrid structures of pyrrolidin-2-one and arylalkylpiperazine as compounds with potential cardiovascular activity*
12:20 00:20:00 Oral Beata Kolesińska Traceless chiral coupling reagent. A new concept for synthesis of optically active products from racemic carboxylic acids.
12:40 00:20:00 Oral Krzysztof Jóźwiak An old drug with new perspectives: How stereochemistry of fenoterol and fenoterol derivatives influences the β-adrenergic binding and the G-protein coupling selectivity.
13:00 00:20:00 Oral Sławomir Milewski N-alkyl derivatives of nystatin with improved selective toxicity
15:20 00:30:00 Invited oral Tomasz Ciach Particles for controlled drug delivery
15:50 00:20:00 Oral Bartłomiej Furman Cyclic Enaminones as Building Blocks in the Synthesis of Piperidine-Containing Natural Products and Biolo- gically Active Compounds
16:10 00:20:00 Oral Zbigniew J. Kamiński An Approach for Application of Synthetic Peptides as Markers of Atherosclerotic Diseases
16:30 00:20:00 Oral Barbara Malawska Multi-target-directed ligands in design and discovery of potential drugs for Alzheimer’s disease

May 11th, Tuesday

09:00 00:30:00 Invited oral Bogusław A. Buszewski New solutions and challenges in chromatography and related techniques. Quo vadis separation sciences?
09:30 00:30:00 Invited oral Jozef Dulak New anti-angiogenic drugs
10:00 00:20:00 Oral Katarzyna A. Koziak Endothelial P2Y receptors as novel targets for a pharmacological intervention
10:20 00:20:00 Oral Kamil K. Kamiński Cationic chitosan derivative for heparin reversal - in vitro and in vivo studies in rats
11:10 00:30:00 Invited oral Grzegorz Węgrzyn The use of genistein in treatment of genetic diseases
11:40 00:20:00 Oral Jan Mazerski Microcalorimetric measurements in design of anti-tumor drugs
12:00 00:20:00 Oral Zofia Lipkowska Design of novel peptide dendrimers: antimicrobial and anticancer activity
12:20 00:20:00 Oral Mateusz Nowak Selvita: Life science solutions
12:40 00:20:00 Oral Artur Panczakiewicz A Local SCF approach to all-atom semiempirical quantum-mechanical protein modeling and ligand docking
15:00 00:30:00 Invited oral Aleksander P. Mazurek Molecular properties of active ingredients Impact on bioavailability The biopharmaceutics classification system
15:30 00:20:00 Oral Ryszard Ostaszewski Chemoenzymatic approach to the synthesis of bioactive tripeptide mimetics for treatment of cancer
15:50 00:20:00 Oral Mariusz Sacharczuk Comparable antinociceptive effect of biphalin in mice selected for high and low swim stress-induced analgesia after blood-brain barrier disruption caused by hyperosmolar mannitol administration
16:10 00:20:00 Oral Małgorzata Milczarek Confocal microscopy - a novel tool in drug analysis

May 12th, Wednesday
09:00 00:30:00 Invited oral Waldemar Priebe Exploration of sugar-based inhibitors of glycolysis to target brain tumors
09:30 00:30:00 Invited oral Marcin Nowotny Protein crystallography as a tool in drug discovery
10:00 00:20:00 Oral Monika Lamparska-Przybysz Novel small molecule STAT3 inhibitors in cancer therapy.
10:20 00:20:00 Oral Teresa M. Brodniewicz Preclinical evaluation of new chemical entity.
11:10 00:30:00 Invited oral Tomasz G. Wasiela Good Laboratory Practice as the quality system ensuring mutual acceptance of test results in the registration of pharmaceutical products.
11:40 00:20:00 Oral Kurt Kristiansen Homology modeling of G-protein coupled receptors
12:00 00:20:00 Oral Andrzej Sikorski Polymer chains as molecular dispensers. Monte Carlo simulations of simple models
12:20 00:20:00 Oral Andrzej W. Lipkowski Keratin associated proteins (KAPs) as a new biomaterials for applications in medicine and cosmetology
12:40 00:20:00 Oral Krzysztof Kurowski New phenylpropanoic acid derivative with antidiabetic potential acting as a partial PPAR gamma agonist – preclinical studies.
15:00 00:30:00 Invited oral Marek Chmielewski From unsaturated sugar α,β-lactones to β-lactams. The synthesis. Od α,β-nienasyconych laktonów cukrowych do syntezy β-laktamów.
15:30 00:20:00 Oral Zbigniew Kałuża Stereoselective synthesis of isoquinoline alkaloids with a quaternary carbon seterocenter
15:50 00:20:00 Oral Lech Kozerski Diffusion ordered  NMR spectroscopy  application  to medicines control and research  
16:10 00:20:00 Oral Zofia Mazerska Polymorphism and the level of P450 gene expression in drug metabolism
16:30 00:20:00 Oral Tomasz Kosmalski   Enantioselective reduction of α-dialkylamino ketones
© 1998-2024 pielaszek research, all rights reserved Powered by the Conference Engine